期刊文献+
共找到1,896篇文章
< 1 2 95 >
每页显示 20 50 100
SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATIENTS WITH ANGINA PECTORIS AND ACUTE MYOCARDIAL INFARCTION 被引量:5
1
作者 尹瑞兴 冯建章 +1 位作者 陈旦红 乌汉东 《Chinese Medical Sciences Journal》 CAS CSCD 2000年第4期205-209,共5页
Objective. To determine whether serum vascular endothelial growth factor(VEGF)concentrations are altered in several kinds of coronary heart disease patients. Materials and methods. Using a VEGF enzyme-linked immunosor... Objective. To determine whether serum vascular endothelial growth factor(VEGF)concentrations are altered in several kinds of coronary heart disease patients. Materials and methods. Using a VEGF enzyme-linked immunosorbent assay(ELISA), serum VEGF concentrations were determined in antecubital venous blood of 16 patients with stable angina pectoris(SAP), 16 with unstable angina pectoris(UAP) and 16 with acute myocardial infarction(AMI) before and after thrombolytic therapy, and of 16 age- and sex-matched healthy volunteers who used as controls. Results. The concentrations of serum VEGF in patients with SAP(9860±2699pg/ml) and UAP (10361±2489pg/ml) tended to be higher than those in control subjects(8044±2457pg/ml), but the differences did not reach statistical significance (P>005 for each). Before thrombolytic therapy, the concentrations of serum VEGF in patients with AMI (28592±12515pg/ml) were significantly higher than those in patients with SAP, UAP or control subjects (P<001,respectively), and correlated with synchronous serum creatine kinase (CK) and its MB isoenzyme (CK-MB) contents(r=0866,P<0001 and r=0948,P<0001;respectively). Three hours after thrombolysis, the concentrations of VEGF had fallen to 11157±3129pg/ml (P<001 vs. before thrombolytic therapy and P<005 vs.control subjects). Conclusion. The present study shows that serum concentrations of VEGF in patients with AMI are markedly elevated and that increased serum VEGF levels may be one of the most sensitive indexes in diagnosing AMI and judging reperfusion. 展开更多
关键词 angina pectoris myocardial infarction vascular endothelial growth factor
在线阅读 下载PDF
Effects of bone marrow-derived mesenchymal stemcells engraftment on vascular endothelial cell growthfactor in lung tissue and plasma at early stage of smoke inhalation injury 被引量:5
2
作者 FengZhu Guang-hua Guo +1 位作者 Wen Chen Nian-yun Wang 《World Journal of Emergency Medicine》 SCIE CAS 2010年第3期224-228,共5页
BACKGROUND: This study was undertaken to determine the effect of mesenchymal stem cells (MSCs) engraftment on vascular endothelial cell growth factor (VEGF) in lung tissue, plasma and extravascular lung water at... BACKGROUND: This study was undertaken to determine the effect of mesenchymal stem cells (MSCs) engraftment on vascular endothelial cell growth factor (VEGF) in lung tissue, plasma and extravascular lung water at early stage of smoke inhalation injury.METHODS: A rabbit smoke inhalation injury model was established using a home-made smoke inhalation injury generator, and rabbits were divided into two groups randomly: a control group (S group, n=32) and a MSCs treatment group (M group, n=32). 10 ml PBS was injected via the ear marginal vein immediately at injury into the S group. Third generation MSCs with a concentration of 1×107/10 ml PBS were injected via the ear marginal vein immediately at injury into the M group. VEGF in peripheral blood and lung tissue were measured at 0 (baseline), 2, 4 and 6 hours after injection respectively and analyzed. The right lungs of rabbits were taken to measure lung water mass fraction.RESULTS: In the lung tissue, VEGF decreased gradually in the S group (P〈0.05) and signi? cantly decreased in the M group (P〈0.05), but it increased more signi? cantly than the values at the corresponding time points (P〈0.05). In peripheral blood, VEGF increased gradually in the S group (P〈0.05) and markedly increased in the M group (P〈0.05), but it decreased more signi? cantly than the values at corresponding time points (P〈0.05).CONCLUSION: MSCs engraftment to smoke inhalation injury could increase VEGF in lung tissue, decrease VEGF in plasma and reduce extravascular lung water, indicating its protective effect on smoke inhalation injury. 展开更多
关键词 Mesenchymal stem cells Smoke inhalation injury Vascular endothelial cell growth factor Extravascular lung water Rabbit
在线阅读 下载PDF
HEPATOCYTE GROWTH FACTOR PROTECTS AGAINST APOPTOSIS INDUCED BY ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS 被引量:2
3
作者 Yi-jun Zhou Jia-he Wang Jin Zhang 《Chinese Medical Sciences Journal》 CAS CSCD 2006年第1期6-10,共5页
Objective To investigate the effects of hepatocyte growth factor(HGF)on vascular endothelial cells apoptosis induced by advanced glycation end products(AGEs)and its possible mechanism. Methods Human umbilical vein end... Objective To investigate the effects of hepatocyte growth factor(HGF)on vascular endothelial cells apoptosis induced by advanced glycation end products(AGEs)and its possible mechanism. Methods Human umbilical vein endothelial cells(HUVECs)were cultured in vitro and intervened by different concentrations of AGEs and HGF.The cell inhibitory rates of each group with different culture time(12, 24, 48, and 72 hours)were measured by methyl thiazolyl tetrazolium(MTT)assay. The early stage apoptosis was detected by flow cytometry with Annexin V-FITC/PI double staining, morphology of cell apoptosis was observed by hoechst 33258 fluorescence staining, and the expression of apoptosis-associated genes Bax and Bcl-2 were determined by Western blotting.The activity of caspase-3 was detected by enzyme-linked immunosorbent assay (ELISA).Results Morphological observation indicated that high concentration of AGEs induced characteristic apoptotic changes in HUVECs.Within a certain concentration range, HUVECs apoptosis inducing rates by AGEs were in both dose- and time-dependent manners.HGF significantly inhibited the apoptosis of HUVECs induced by AGEs (P< 0.05).AGEs significantly promoted expression of Bax protein, but not Bcl-2.Whereas HGF significantly promoted the expression of Bcl-2(P<0.01)and decreased the activity of caspase-3(P<0.05)without affecting Bax level.Conclusions AGEs can induce the apoptosis of endothelial cells in vitro.HGF may effectively attenuate AGEs-induced endothelial cells apoptosis through upregulating Bcl-2 gene expression and inhibiting caspase-3 activation. 展开更多
关键词 hepatocyte growth factor advanced glycation end products vascular endothelial cell APOPTOSIS ATHEROSCLEROSIS
在线阅读 下载PDF
Zinc Finger Protein-activating Transcription Factor Up-regulates Vascular Endothelial Growth Factor-A Expression in Vitro 被引量:2
4
作者 Li-shan Lian Yao-guo Yang +4 位作者 Wei Liu Li-long Guo Heng Guan Chang-wei Liu Yong-jun Li 《Chinese Medical Sciences Journal》 CAS CSCD 2012年第3期171-175,共5页
Objective To construct the zinc finger protein-activating transcription factor (ZFP-ATF) plasmid and evaluate its efficacy in inducing vascular endothelial growth factor (VEGF) expression in EY.HY926 endothelial cells... Objective To construct the zinc finger protein-activating transcription factor (ZFP-ATF) plasmid and evaluate its efficacy in inducing vascular endothelial growth factor (VEGF) expression in EY.HY926 endothelial cells. Methods Firstly, we constructed the ZFP-ATF plasmid, then testified the quantity of VEGF protein in EY.HY926 endothelial cells after transfected with ZFP-ATP plasmid by Western blot, finally, we used the RT-PCR to testify whether the ZFP-ATF can stimulate expression of VEGF splice variants. Results The ZFP-ATF DNA sequences were located the multiclone sites of PVAX1 vector between the site of BamH Ⅰ and Xhol. Western blot result showed VEGF expression in EY.HY926 endothelial cells transfected with ZFP-ATF plasmid was significantly higher than that in cells transfected with VEGF165 (19.95±3.95 vs. 12.15±1.55 μg/μL, P<0.01). RT-PCR result showed VEGF-A mRNA expression level induced by ZFP-ATF was high than that induced by VEGF165. Conclusion ZFP-ATF can up-regulate the VEGF-A expression in comparison with VEGF165, which might have beneficial effects in angiogenesis process. 展开更多
关键词 zinc finger protein-activating transcription factor vascular endothelial growth factor ANGIOGENESIS
在线阅读 下载PDF
DYNAMIC CHANGES OF SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS IN A RAT MYOCARDIAL INFARCTION MODEL 被引量:2
5
作者 尹瑞兴 冯建章 姚震 《Chinese Medical Sciences Journal》 CAS CSCD 2000年第3期154-156,共3页
To investigate the dynamic changes of serum vascular endothelial growth factor(VEGF) levels in a rat model of acute myocardial infarction. Materials and methods.Eighty eight adult male Sprague Dawley rats weighing app... To investigate the dynamic changes of serum vascular endothelial growth factor(VEGF) levels in a rat model of acute myocardial infarction. Materials and methods.Eighty eight adult male Sprague Dawley rats weighing approximately 270 g were used in this study. Eighty rats were subjected to left coronary artery ligation, with 8 rats for each different duration of infarct. Eight sham operated animals in which the left coronary artery was surgically exposed without ligation were used as controls. Blood samples were drawn from the right atrium before (sham animals) and 1,3,6,12,24 h and 2,3,5,7,14 d after myocardial infarction. The concentrations of serum VEGF were measured by a sensitive enzyme linked immunosorbent assay with a rabbit polyclonal antibody specific for VEGF. Results. In the 8 control animals, the mean concentration of serum VEGF was 66.99±17.83 pg/ml. Six hours after myocardial infarction, the level of serum VEGF significantly increased to 125.68±28.07 pg/ml (P<0.01 vs. sham controls), and reached a peak (240.61±70.63 pg/ml. P<0.01 vs. sham animals) at 24 h after ligation and then decreased gradually over the remaining 2 weeks. However, the level remained significantly elevated for 14 d (107.64±30.13pg/ml, P<0.01 vs. sham controls). Conclusion. The present study shows that the levels of serum VEGF are markedly increased until 14 d in the rat model of acute myocardial infarction. The increased serum VEGF level may play an important role in the angiogenesis associated with myocardial infarction. 展开更多
关键词 myocardial infarction vascular endothelial growth factor enzyme linked immunosorbent assay
在线阅读 下载PDF
REGULATING EFFECTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ANG Ⅱ ON FROG'S PERICARDIAL STOMATA, MESOTHELIUM AND ANGIOGENESIS 被引量:1
6
作者 李继承 周吉林 +2 位作者 BrunoTota GiusyScalia AlfonsinaGattuso 《Chinese Medical Sciences Journal》 CAS CSCD 2001年第1期23-28,共6页
To observe the regulating effects of vascular endothelial growth factor (VEGF) and angiotensinⅡ (ANG II) on the frog’s pericardium, lymphatic stomata and angiogenesis so as to reveal their effects and mechanism on t... To observe the regulating effects of vascular endothelial growth factor (VEGF) and angiotensinⅡ (ANG II) on the frog’s pericardium, lymphatic stomata and angiogenesis so as to reveal their effects and mechanism on the mesothelial permeability, lymphatic stoma regulation and myocardial hypertrophy. Methods. VEGF and ANGⅡ were injected into the frog’s peritoneal cavity so as to examine the changes of the pericardial stromata by using transmission electron microscopy, scanning electron microscopy and computerized imaging analysis. Results. Scattered distributed pericardial stomata were found on the parietal pericardium of the frog with a few sinusoid mesothelial cells, whose blood supply was directly from the cardiac chambers flowing into the trabecular spaces of the myocardium (because there are no blood vessels in the myocardium of the frog). The average diameters of the pericardial stomata in VEGF and ANGⅡ groups were 1.50μ m and 1.79μ m respectively, which were much larger than those in the control group (0.72μ m, P Conclusions. VEGF and ANGⅡ could strongly regulate the pericardial stomata by increasing their numbers and openings with larger diameters and higher distribution density. They could also increase the sinusoid areas with the result of the higher permeability of the pericardium, which clearly indicated that VEGF and ANGⅡ could speed up the material transfer of the pericardial cavity and play an important role in preventing myocardial interstitial edema. Yet there was no strong evidence to show the angiogenesis in the myocardium. 展开更多
关键词 vascular endothelial growth factor angioteinsin II lymphatic stomata
在线阅读 下载PDF
Detection of expression of vascular endothelial growth factor C/VEGFR-3 in early stage cervical cancer by tissue microarray assay and its significance 被引量:1
7
作者 SHANG Hai-xia WU Su-hui LI Ying 《山西医科大学学报》 CAS 2009年第9期845-849,共5页
关键词 早期子宫癌 诊断 淋巴结转移 动脉血管
在线阅读 下载PDF
Vascular endothelial growth factor promotes angiogenesis in gastric carcinoma
8
作者 刘都户 张学庸 +2 位作者 黄峪新 粟永萍 樊代明 《Journal of Medical Colleges of PLA(China)》 CAS 2002年第1期73-78,共6页
Objective: To explore the role of vascular endothelial growth factor (VEGF) in the angiogenesis and development of human gastric carcinoma. Methods: The expressions of VEGF and its receptor KDR (ki-nase-domain insert ... Objective: To explore the role of vascular endothelial growth factor (VEGF) in the angiogenesis and development of human gastric carcinoma. Methods: The expressions of VEGF and its receptor KDR (ki-nase-domain insert containing receptor) in human gastric cancer tissue and SGC-7901 cells were detected with immunohistochemical staining. Microvessel density (MVD) was obtained after immunostaining for Factor-VIII. VEGF in SGC-7901 cell line was detected with Western blot. VEGF levels were manipulated in human gastric cancer cell by using eukaryotic expression vector containing the complete VEGF165 complimentary DNA in either the sense or antisense orientation. Finally the biological characteristics of the transfectants were identified. Results: VEGF-positive rate in TNM grade I and IV gastric carcinomas (19. 0%) were significantly higher than that in grade I and I (72. 4%) (P<0. 05). Increased MVD was found in VEGF-positive tumors (16. 4±6. 7). which is significantly larger than in VEGF-negative tumors (6. 5±2. 1) (P< 0. 05). Human gastric cancer cells (SGC-7901) produced 3 kinds of VEGF in molecule. In 2 cases of 50 specimens, a few gastric cancer cells expressed KDR in cytoplasm and cell membranes. SGC-7901 cells with anti-sense VEGF165 showed a significant reduction in cell surface VEGF protein with the immunofluorescence intensity from 8. 9% to 31. 6% (P<0. 05). However, those with stable integration of VEGF165 in the sense orientation resulted in an increase in cellular and cell surface VEGF with the immunofluorescence intensity from 75. 4% to 31. 6% (P<0. 05). The decrease of VEGF levels was associated with a marked decrease in the growth of nude mouse xenografted tumor (33 d post-implantation, 345. 4±136. 3 mm3 in size) (P<0. 05 vs control SGC-7901 group) , whereas VEGF overexpression resulted in an increase of xenografted tumor size (33 d post-implantation, 2 350. 5±637. 7 mm3 in size) (P<0. 05 vs control SGC-7901 group). Conclusion: VEGF plays an important role in the development of human gastric cancer, and might have an autocrine effect upon the gastric cancer cells. The inhibition of VEGF by antisense RNA expression might prevent solid tumor from growing and metastasizing. 展开更多
关键词 vascular endothelial growth factor ANGIOGENESIS stomach neoplasm
在线阅读 下载PDF
THE EXPRESSIONS AND SIGNIFICANCES OF p15,p16 AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN GASTRIC CARCINOMA
9
作者 王天宝 高鹏 +2 位作者 曲延刚 陈咸增 李兆亭 《中国现代普通外科进展》 CAS 2000年第2期29-31,共3页
To investigate the relationships between the expressions of p15,p16 and vascular endothelial growth factor (VEGF) and gastric carcinoma(GC). Methods: Using Immunohistochemical staining to examine the expressions of p1... To investigate the relationships between the expressions of p15,p16 and vascular endothelial growth factor (VEGF) and gastric carcinoma(GC). Methods: Using Immunohistochemical staining to examine the expressions of p15, p16 and VEGF In archival wax-embedded specimens of 80 GC and 20 gastric benign disease (GBD). Results: The positive expression rate (PER) of p15 was significantly lower in GC than in GBD (43.75% VS. 69.23%, P<0.05). No relationship was found between PER of p15 and clinicopathologic factors. PER of p16 was 20% in GC, 55% in GBD (P<0.01). PER of p16 wasn't significantly different in gross types, histological types, with or without distant metastasis and pTNM stages. PER of p16 was 71.43% in invasive mucosa or submucosa group, 17.24% in invasive muscle group and 13.64% in invasive serosa group (P<0.01); 12.96% in GC with lymph nodes metastasis, 34.62% in GC without lymph node metastasis (P<0.05). PER of VEGF in GC was 75.00%, in GBD 7.69% (P<0.001), in ul-cerative type of GC and infiltrating 展开更多
关键词 P15基因 p16基因 胃癌 血管内皮生长因子 免疫组织化学 基因表达 肿瘤生物学
在线阅读 下载PDF
Skeletal myoblast based delivery of angiogenic growth factors:a comparison between angiopoietin-1 and VEGF gene delivery for therapeutic angiogenesis in the heart 被引量:3
10
作者 Husnain Kh Haider In-Chin Song +1 位作者 Peter K Law Eugene KW Sim 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2006年第3期152-160,共9页
Objectives This study investigated the efficacy of human skeletal myoblasts (SkM) mediated either human vascular endothelial growth factor-165 (hVEGF165) or angiopoietin-1 (Ang-1) on vascular development and myocardia... Objectives This study investigated the efficacy of human skeletal myoblasts (SkM) mediated either human vascular endothelial growth factor-165 (hVEGF165) or angiopoietin-1 (Ang-1) on vascular development and myocardial regional perfusion. Methods A porcine heart model of chronic infarction was created in 28 female swine by coronary artery ligation. The animals were randomized into: (1) group-1, DMEM injected (n=6), (2) group-2, Ad-null transduced SkM transplanted (n=6), (3) group-3, Ad-hVEGF165 transduced SkM transplanted (n=8), and (4) group-4, Ad-Ang-1 transduced SkM (n=8). Three weeks later, 5 ml DMEM containing 3×108 SkM carrying exogenous genes were intramyocardially injected into 20 sites in left ventricle in groups-2, -3 and -4. Animals in group-1 were injected 5 ml DMEM without cells. Animals were kept on 5 mg/kg cyclosporine per day for 6 weeks. Regional blood flow was measured using fluorescent microspheres. The heart was explanted at 2, 6 and 12 weeks after transplantation for histological studies. Results Histological examination showed survival of lac-z expressing myoblasts in host tissue. Capillary density based on Von Willebrand factor-VIII (vWF-VIII) at low power field (×100) was 57.13±11.85 in group-3 at 6 weeks and declined to 32.1±5.21 at 12 weeks, while it was 39.9±10.26 at 6 weeks and increased to 45.14±6.54 at 12 weeks in group-4. The mature blood vessel index was highest in group- 4 at 6 and 12 weeks after transplantation. The regional blood flow in the center and peri-infarct area was significantly increased in animals of groups-3 and -4. Conclusions SkM carrying either hVEGF165 or Ang-1 induced neovascularization with increased blood flow. Ang-1 overexpression resulted in mature and stable blood vessel formation and may be a more potent arteriogenic inducer for neovascularization. 展开更多
关键词 therapeutic angiogenesis SKELETAL MYOBLASTS vascular endothelial growth factor-165 ANGIOPOIETIN-1 MYOCARDIAL INFARCTION
在线阅读 下载PDF
玻璃体内注射抗VEGF药物联合全视网膜激光光凝术(PRP)治疗不同程度中青年PDR患者的临床疗效
11
作者 石蕊 秦静 +2 位作者 龚小羽 李卓明 刘丹丹 《眼科新进展》 北大核心 2025年第3期216-220,共5页
目的探讨玻璃体内注射抗VEGF药物联合全视网膜激光光凝术(PRP)治疗不同严重程度的中青年增生型糖尿病视网膜病变(PDR)患者的临床疗效。方法本研究为回顾性病例研究,选取2021年1月1日至2024年10月1日就诊于陕西省人民医院眼科的糖尿病视... 目的探讨玻璃体内注射抗VEGF药物联合全视网膜激光光凝术(PRP)治疗不同严重程度的中青年增生型糖尿病视网膜病变(PDR)患者的临床疗效。方法本研究为回顾性病例研究,选取2021年1月1日至2024年10月1日就诊于陕西省人民医院眼科的糖尿病视网膜病变(DR)患者,依据我国糖尿病视网膜病变临床诊疗指南(2022年),将患者分为重度非增生型糖尿病视网膜病变组(NPDR组)、增生早期PDR组(E-PDR组)和纤维增生期DR组(F-PDR组),共纳入DR患者53例94眼,年龄(41.66±10.24)岁;其中,NPDR组17例31眼,E-PDR组18例33眼,F-PDR组18例30眼。所有患者均接受抗VEGF药物(雷珠单抗0.5 mg)玻璃体内注射,注射部位统一为颞下方角膜缘后3.5 mm,每月1次,连续3次,第1次注射后1周常规行PRP治疗,分别于第一次注射治疗后1个月、3个月进行最佳矫正视力[BCVA(logMAR)]、眼压监测以及裂隙灯检查、裂隙灯下眼底检查、欧堡照相及OCT检查,分别记录患者黄斑中心凹视网膜厚度(CMT)及平均厚度(AMT),玻璃体积血和视网膜前膜形成的发生率。结果与NPDR组和E-PDR组相比,F-PDR组患者年龄更小(均为P<0.05)。治疗后3个月,三组患眼BCVA较治疗前均有不同程度提高(均为P<0.05);治疗后3个月,与NPDR组及E-PDR组相比,F-PDR组患眼的视力预后更差,差异均有统计学意义(均为P<0.05)。治疗后3个月,三组患眼CMT及AMT均较治疗前明显降低(均为P<0.05),但三组患眼同时期组间比较差异均无统计学意义(均为P>0.05)。治疗后3个月,与NPDR组和E-PDR组相比,F-PDR组发生玻璃体积血及视网膜前膜的风险更高(均为P<0.05)。结论对于中青年PDR患者而言,玻璃体内抗VEGF药物注射联合PRP是早期控制病情进展的有效手段,可显著提高患者的视力;伴有纤维增殖的PDR患者进行抗VEGF药物注射联合PRP治疗时发生玻璃体积血和视网膜前膜的风险更高,需要严密随访,必要时需及时行玻璃体切割术解除视网膜牵拉。 展开更多
关键词 增生型糖尿病视网膜病变 全视网膜光凝 抗血管内皮生长因子药物 最佳矫正视力 黄斑中心凹视网膜厚度
在线阅读 下载PDF
病理性近视脉络膜新生血管的药物治疗新进展
12
作者 张宁晖 解孝锋 +1 位作者 田庆梅 毕宏生 《眼科新进展》 CAS 北大核心 2025年第1期66-70,共5页
病理性近视脉络膜新生血管(PM-CNV)是导致病理性近视患者视力丧失的常见并发症,其发病机制涉及机械牵拉、缺氧和炎症等诸多因素。抗血管内皮生长因子疗法是治疗PM-CNV的有效方法,雷珠单抗、阿柏西普和康柏西普等抗血管内皮生长因子药物... 病理性近视脉络膜新生血管(PM-CNV)是导致病理性近视患者视力丧失的常见并发症,其发病机制涉及机械牵拉、缺氧和炎症等诸多因素。抗血管内皮生长因子疗法是治疗PM-CNV的有效方法,雷珠单抗、阿柏西普和康柏西普等抗血管内皮生长因子药物经临床试验证实均能改善PM-CNV患者视力,但各有其特点和适用范围。本文综述了PM-CNV药物治疗的最新进展,以期为临床治疗该病提供参考。 展开更多
关键词 脉络膜新生血管 抗血管内皮生长因子 疗效比较 光学相干断层扫描
在线阅读 下载PDF
成年人咽、喉乳头状瘤的临床特征与人乳头状瘤病毒、缺氧诱导因子、血管内皮生长因子表达的相关性
13
作者 郭奕荟 马丽晶 +1 位作者 肖洋 王军 《中国耳鼻咽喉头颈外科》 2025年第1期42-47,共6页
目的探讨咽、喉乳头状瘤患者的临床特征与人乳头状瘤病毒(HPV)感染及缺氧诱导因子(hypoxia-inducible factor,HIF)、血管内皮生长因子(VEGF)表达的关系。方法选择首都医科大学附属北京同仁医院2022年10月~2024年2月收治的成年人咽、喉... 目的探讨咽、喉乳头状瘤患者的临床特征与人乳头状瘤病毒(HPV)感染及缺氧诱导因子(hypoxia-inducible factor,HIF)、血管内皮生长因子(VEGF)表达的关系。方法选择首都医科大学附属北京同仁医院2022年10月~2024年2月收治的成年人咽、喉乳头状瘤患者作为试验组,成年人非炎症非肿瘤咽喉病变患者作为对照组,收集其临床资料和病变组织样本,比较咽、喉乳头状瘤患者在症状、年龄、性别、吸烟、饮酒、病变累及部位数量和手术次数等方面的差异,采用实时荧光定量PCR技术检测病变组织中HPV DNA、HIF cDNA、VEGF cDNA的表达。结果咽乳头状瘤患者症状轻于喉乳头状瘤患者,两组患者在性别、饮酒方面的差异无统计学意义(P>0.05),在年龄、吸烟、病变累及部位数量和手术次数方面的差异有统计学意义(P<0.05)。病变累及部位数量与HIF、VEGF的表达呈正相关(r=0.3553、r=0.2693,P<0.05),手术次数与VEGF的表达呈正相关(r=0.2515,P<0.05),HIF、VEGF在喉乳头状瘤中的表达水平均高于咽乳头状瘤和对照组(F=9.174、H=23.737,P<0.001),HIF、VEGF在HPV阳性组织中的表达水平均高于HPV阴性组织(t=3.899、t=6.463,P<0.001),喉乳头状瘤的HPV阳性率(97.9%,46/47)高于咽乳头状瘤(21.7%,10/46)和对照组(13.6%,3/22)(χ^(2)=53.114、χ^(2)=46.647,P<0.001)。结论HPV感染是咽乳头状瘤发生的重要原因之一,其低感染状态可能导致瘤体HIF、VEGF低表达,从而使其临床特征不同于喉乳头状瘤。 展开更多
关键词 乳头状瘤 人乳头状瘤病毒 血管内皮生长因子 缺氧诱导因子
在线阅读 下载PDF
肾浊方通过抑制肾小球内皮细胞异常血管新生治疗早期糖尿病肾脏疾病的作用机制研究
14
作者 张家义 陈雅欣 +7 位作者 张玉凤 王希 李伟 刘雪梅 万倩慧 孙振华 王文波 李玉杰 《长春中医药大学学报》 2025年第3期272-277,共6页
目的 探讨肾浊方对肾小球内皮细胞迁移和血管生成的影响,以及其在治疗早期糖尿病肾脏疾病(DKD)中的潜在作用机制。方法 研究采用自发性2型糖尿病db/db小鼠(在8周龄时出现肾损伤)来研究肾浊方对DKD的影响。采用小鼠肾小球内皮细胞(MGECs... 目的 探讨肾浊方对肾小球内皮细胞迁移和血管生成的影响,以及其在治疗早期糖尿病肾脏疾病(DKD)中的潜在作用机制。方法 研究采用自发性2型糖尿病db/db小鼠(在8周龄时出现肾损伤)来研究肾浊方对DKD的影响。采用小鼠肾小球内皮细胞(MGECs)建立体外高糖模型来研究肾浊方对MGECs迁移和血管生成能力的影响。结果 肾浊方可以改善db/db小鼠的肾损伤。Western blot和免疫组织化学显示,db/db小鼠中血管内皮生长因子(VEGFA)、血管内皮生长因子受体-2(VEGFR2)、水通道蛋白-1(AQP1)和血小板-内皮细胞黏附分子(CD31)的蛋白表达水平升高,而肾浊方处理则降低了这些蛋白的表达。在MGECs高糖模型中,肾浊方可能通过改变VEGFA、VEGFR2、AQP1和CD31的表达来逆转高糖环境中MGECs的迁移能力和血管生成能力的增强。此外,药物效果随着肾浊方浓度的增加而逐渐增强。结论 肾浊方可通过抑制肾小球内皮细胞的迁移和血管生成来改善DKD早期的肾损伤,从而进一步明确了肾浊方的作用机制。此外,本研究发现DKD中AQP1的表达增加,为进一步研究DKD的潜在发病机制提供了新的视角。 展开更多
关键词 肾浊方 糖尿病肾脏疾病 异常血管新生 血管内皮生长因子A 水通道蛋白1
在线阅读 下载PDF
抗VEGF药物治疗糖尿病视网膜病变的伞状系统评价
15
作者 令娟 关婧楠 +2 位作者 罗向霞 谢卓霖 罗旭飞 《眼科新进展》 北大核心 2025年第2期108-114,共7页
目的对抗血管内皮生长因子药物(VEGF)治疗糖尿病视网膜病变(DR)的系统评价/Meta分析研究进行伞状系统评价,并以质量评价工具AMSTAR 2及PRISMA对文献质量进行评价,通过图表结合的形式展示证据质量的分布特征。方法计算机检索中英文数据库... 目的对抗血管内皮生长因子药物(VEGF)治疗糖尿病视网膜病变(DR)的系统评价/Meta分析研究进行伞状系统评价,并以质量评价工具AMSTAR 2及PRISMA对文献质量进行评价,通过图表结合的形式展示证据质量的分布特征。方法计算机检索中英文数据库,包括The Cochrane Library、PubMed、EMbase、CBM、万方及CNKI数据库,获取基于抗VEGF药物治疗DR的系统评价/Meta分析文献,检索时限均为建库至2024年3月。由2位评价员独立阅读文献并提取资料后,采用AMSTAR 2量表和PRISMA声明对纳入文献的方法学质量和报告质量进行伞状评价。结果最终纳入研究27篇,抗VEGF药物治疗DR系统评价/Meta分析的方法学质量及报告学质量为中等偏低质量。AMSTAR 2评价结果显示,对前期研究方案预先制定及纳入研究的资助来源等内容的阐述亟待提高;PRISMA结果显示,影响报告质量的条目内容主要为方案与注册、文献检索、补充分析与资助来源等。结论抗VEGF药物治疗DR的系统评价/Meta分析的方法学质量和报告学质量有待提高,在撰写系统评价/Meta分析的文章时研究者应当注意遵照AMSTAR 2量表和PRISMA声明要求以提升其方法学的质量和报告规范,从而提供更高质量证据等级的文献。 展开更多
关键词 抗血管内皮生长因子药物 糖尿病视网膜病变 伞状评价 AMSTAR 2 PRISMA
在线阅读 下载PDF
儿童过敏性紫癜与血管内皮生长因子受体3的相关性分析
16
作者 何扬 王大燕 +1 位作者 吴绿仙 傅海东 《浙江临床医学》 2025年第1期96-98,共3页
目的 探讨血管内皮生长因子受体3(VEGFR3)与儿童过敏性紫癜的相关性。方法 收集2022年1~12月本院139例过敏性紫癜患儿的临床资料。其中过敏性紫癜81例,过敏性紫癜肾炎58例。另选择同期37例体检健康儿童为对照组。比较各组血清VEGFR3水... 目的 探讨血管内皮生长因子受体3(VEGFR3)与儿童过敏性紫癜的相关性。方法 收集2022年1~12月本院139例过敏性紫癜患儿的临床资料。其中过敏性紫癜81例,过敏性紫癜肾炎58例。另选择同期37例体检健康儿童为对照组。比较各组血清VEGFR3水平。结果过敏性紫癜肾炎组与过敏性紫癜组血清VEGFR3低于健康儿童,差异有统计学意义(P<0.05)。结论 过敏性紫癜儿童血清VEGFR3降低,VEGFR3/VEGFR2/VEGF通路在儿童过敏性紫癜的发病中起重要作用。 展开更多
关键词 过敏性紫癜 血管内皮生长因子 血管内皮生长因子受体3
在线阅读 下载PDF
脑膜瘤磁共振成像与血管内皮生长因子的关系
17
作者 王晓宁 焦红亮 肖新广 《河南医学研究》 2025年第1期1-6,共6页
目的探索不同级别脑膜瘤血管内皮生长因子(VEGF)与MRI的关系,研究不同级别脑膜瘤的发生和进展中的临床病理生物学特征,为临床诊疗及评估提供理论支持。方法选取2009年5月至2022年9月经郑州大学第一附属医院和郑州市中心医院神经外科手... 目的探索不同级别脑膜瘤血管内皮生长因子(VEGF)与MRI的关系,研究不同级别脑膜瘤的发生和进展中的临床病理生物学特征,为临床诊疗及评估提供理论支持。方法选取2009年5月至2022年9月经郑州大学第一附属医院和郑州市中心医院神经外科手术并病理证实的38例脑膜瘤患者。采用德国SIEMENS超导3.0 T磁共振成像系统行MRI平扫和动态增强扫描。肿瘤组织标本应用Western-blot、免疫组化和RT-PCR等技术,对不同级别脑膜瘤标本中的VEGF表达情况进行分析。结果Western-blot、免疫组化和RT-PCR结果提示,在不同级别脑膜瘤中,VEGF的表达有统计学意义(P<0.05)。其中Ⅲ级脑膜瘤组表达最高,Ⅰ级脑膜瘤组表达较Ⅱ级降低,Ⅱ级脑膜瘤组表达较Ⅲ级降低(P<0.05),但正常脑膜和Ⅰ级脑膜瘤相比则差异无统计学意义(P>0.05)。VEGF表达量与MRI信号增强程度、T_(2)加权成像(T_(2)WI)、T_(1)加权成像(T_(1)WI)信号强度及瘤周水肿(PTBE)呈正相关(P<0.05),但是与瘤周侵犯的范围及硬膜鼠尾征无相关(P>0.05)。结论VEGF表达量与脑膜瘤的级别呈正相关,在Ⅲ级脑膜瘤组中表达量最高,此外,脑膜瘤中的VEGF表达与T_(1)WI信号强度、T_(2)WI信号强度、PTBE和增强程度等保持一定的关联性,然而却与瘤周侵犯范围及脑膜尾征无关联。Ⅲ级脑膜瘤表达VEGF最高,VEGF的表达直接关联到脑膜瘤级别,高水平表达的VEGF可协同作用于肿瘤的浸润、增殖,同时让PTBE的形成变得更加容易。 展开更多
关键词 脑膜瘤 磁共振成像 血管内皮生长因子
在线阅读 下载PDF
超声弹性成像联合血清VEGF、IL-17水平对甲状腺癌分化程度的鉴别效能
18
作者 林德威 张周龙 《罕少疾病杂志》 2025年第3期48-50,共3页
目的 分析超声弹性成像联合血清血管内皮生长因子(VEGF)、白细胞介素-17(IL-17)水平对甲状腺癌分化程度的鉴别效能。方法 回顾性研究本院收治的268例甲状腺癌患者的临床资料,参照临床判断结果将其分为中/高分化组(187例)、低分化组(81例... 目的 分析超声弹性成像联合血清血管内皮生长因子(VEGF)、白细胞介素-17(IL-17)水平对甲状腺癌分化程度的鉴别效能。方法 回顾性研究本院收治的268例甲状腺癌患者的临床资料,参照临床判断结果将其分为中/高分化组(187例)、低分化组(81例)。比较两组患者超声弹性成像相关参数(弹性比值、蓝色面积比值)以及血清VEGF、IL-17水平;绘制受试者工作特征(ROC)曲线分析超声弹性成像、血清VEGF、IL-17单独及联合对甲状腺癌分化程度的鉴别价值。结果 中/高分化组的弹性比值、蓝色面积比值、血清VEGF和IL-17水平均低于低分化组(P<0.05)。弹性比值、蓝色面积比值联合鉴别甲状腺癌分化程度的曲线下面积(AUC)、灵敏度、特异度分别为0.901、85.19%、87.70%,其中联合灵敏度高于单独单独鉴别,联合AUC高于单独鉴别(P<0.05),特异度与单独鉴别相近;超声弹性成像参数联合血清VEGF、IL-17鉴别甲状腺癌分化程度的的AUC、灵敏度、特异度分别为0.963、96.30%、84.49%,其中联合灵敏度高于单独单独鉴别,联合AUC高于单独鉴别(P<0.05),特异度与单独鉴别相近。结论 超声弹性成像参数与血清VEGF、IL-17均可有效鉴别甲状腺癌分化程度,但其联合鉴别价值更高。 展开更多
关键词 甲状腺癌 超声弹性成像 血管内皮生长因子 白细胞介素-17 分化程度 鉴别效能
在线阅读 下载PDF
多波长眼底激光联合抗VEGF对糖尿病视网膜病变患者玻璃体黄斑界面的影响研究
19
作者 李雨 孙冬敏 李英俊 《临床眼科杂志》 2025年第1期13-16,共4页
目的探讨多波长眼底激光联合抗血管内皮生长因子(VEGF)在糖尿病视网膜病变(DR)患者中的效果及对玻璃体黄斑界面(VMI)的影响。方法前瞻性病例对照研究。选择2023年7~11月DR患者100例(100只眼)为研究对象,信封法分为两组各50例。对照组采... 目的探讨多波长眼底激光联合抗血管内皮生长因子(VEGF)在糖尿病视网膜病变(DR)患者中的效果及对玻璃体黄斑界面(VMI)的影响。方法前瞻性病例对照研究。选择2023年7~11月DR患者100例(100只眼)为研究对象,信封法分为两组各50例。对照组采取多波长眼底激光治疗,观察组联合抗VEGF治疗,两组治疗5周后评估患者效果,比较两组最佳矫正视力(BCVA)、症状消失时间、视网膜中央动、静脉血流动力学参数、玻璃体黄斑界面及并发症发生率。结果观察组干预5周后BCVA高于对照组(P<0.05);眼底出血吸收、渗出吸收及黄斑水肿改善时间短于对照组(均P<0.05);观察组干预5周后动脉视网膜中央动脉峰值血流速度(PSV)、平均血流速度(MV)、舒张末期血流速度(EDV)和中央静脉最大血流速度(Vmax)、最低血流速度(Vmin)及(MV水平)低于对照组(均P<0.05);静脉波动指数(PI)及阻力指数(RI)低于对照组(均P<0.05);观察组VIM、黄斑水肿、玻璃体出血、视网膜出血及新的无灌注区发生率低于对照组(均P<0.05)。结论多波长眼底激光联合抗VEGF能缩短DR患者症状消失时间,提高BCVA,改善视网膜中央动、静脉血流动力学水平,能降低VMI发生率,且患者治疗安全性较高,值得推广应用。 展开更多
关键词 多波长眼底激光 抗血管内皮生长因子 糖尿病视网膜病变 玻璃体黄斑界面
在线阅读 下载PDF
基因补充与CRISPR/Cas9基因编辑在新生血管性眼底病中的应用
20
作者 秦勋 刘张愉 +1 位作者 黄嘉钰 姚进 《眼科新进展》 北大核心 2025年第3期233-237,共5页
新生血管性眼底病包括新生血管性年龄相关性黄斑变性(nAMD)和糖尿病视网膜病变(DR)等。病理性新生血管渗漏及其继发的视网膜脱离等是导致患者视力受损的主要原因。抗血管内皮生长因子(Anti-VEGF)是新生血管性眼底病的一线治疗药物,但存... 新生血管性眼底病包括新生血管性年龄相关性黄斑变性(nAMD)和糖尿病视网膜病变(DR)等。病理性新生血管渗漏及其继发的视网膜脱离等是导致患者视力受损的主要原因。抗血管内皮生长因子(Anti-VEGF)是新生血管性眼底病的一线治疗药物,但存在需要频繁眼内注射、患者依从性差等问题。目前nAMD、DR等新生血管性眼底病的发病率逐年升高,因此迫切需要找到更安全长效的治疗方式。近年来,基因治疗领域迅速发展,其治疗策略主要包括基因补充和基因编辑。基因治疗的作用机制可以概括为:纠正缺陷基因导致的病理改变,如引入外源性正常基因或直接在基因组水平上修饰异常基因。大量基础和临床研究证明基因治疗是安全且有效的。目前,数十项视网膜基因治疗的临床试验正在开展,除遗传性视网膜病变外,新生血管性眼底病也是热门研究领域。本文重点总结了近年来基因补充、成簇的规律间隔的短回文重复序列(CRISPR)及CRISPR相关蛋白9 (Cas9)系统在nAMD和DR中的应用。 展开更多
关键词 新生血管性眼底病 基因补充 CRISPR/Cas9 抗血管内皮生长因子
在线阅读 下载PDF
上一页 1 2 95 下一页 到第
使用帮助 返回顶部